Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections

被引：23

作者：

Carrillo-Muñoz, AJ

Quindós, G

Ruesga, M

Alonso, R

del Valle, O

Hernández-Molina, JM

McNicholas, P

Loebenberg, D

Santos, P

机构：

[1] ACIA, Dept Microbiol, E-08080 Barcelona, Spain

[2] Univ Basque Country, Fac Med, Dept Inmunol Microbiol & Parasitol, E-48080 Bilbao, Spain

[3] Hosp Valle De Hebron, Microbiol Serv, Barcelona, Spain

[4] Hosp Inmaculada, Microbiol Serv, Huercal Overa, Almeria, Spain

[5] Schering Plough Res Inst, Kenilworth, NJ USA

[6] Hosp Pediat Pablo Garrahan, Buenos Aires, DF, Argentina

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2005年 / 55卷 / 03期

关键词：

susceptibility; opportunistic; Candida;

D O I：

10.1093/jac/dki022

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

Objectives: The in vitro antifungal activity of posaconazole was compared with that of fluconazole and amphotericin B. Materials and methods: A microdilution method (M27-A2) was used with 331 clinical yeast isolates. Results: The geometric mean MICs of posaconazole, fluconazole and amphotericin B were 0.16, 0.91 and 0.15 mg/L, respectively. Posaconazole was markedly more active than fluconazole and was active against 9/11 fluconazole-resistant Candida albicans, and five Candida glabrata had an MIC of posaconazole of 16 mg/L. Conclusions: These data indicate that posaconazole is a potentially effective antifungal agent for the treatment of mycoses caused by yeasts.

引用

收藏

页码：317 / 319

页数：3

相关论文

共 28 条

[1] Activity of the new antifungal triazole, posaconazole, against Cryptococcus neoformans [J].

Barchiesi, F ;

Schimizzi, AM ;

Caselli, F ;

Giannini, D ;

Camiletti, V ;

Fileni, B ;

Giacometti, A ;

Di Francesco, LF ;

Scalise, G .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2001, 48 (06) :769-773

[2] Quality control limits for broth microdilution susceptibility tests of ten antifungal agents [J].

Barry, AL ;

Pfaller, MA ;

Brown, SD ;

Espinel-Ingroff, A ;

Ghannoum, MA ;

Knapp, C ;

Rennie, RP ;

Rex, JH ;

Rinaldi, MG .

JOURNAL OF CLINICAL MICROBIOLOGY, 2000, 38 (09) :3457-3459

[3] In vitro and in vivo activities of SCH 56592 (posaconazole), a new triazole antifungal agent, against Aspergillus and Candida [J].

Cacciapuoti, A ;

Loebenberg, D ;

Corcoran, E ;

Menzel, F ;

Moss, EL ;

Norris, C ;

Michalski, M ;

Raynor, K ;

Halpern, J ;

Mendrick, C ;

Arnold, B ;

Antonacci, B ;

Parmegiani, R ;

Yarosh-Tomaine, T ;

Miller, GH ;

Hare, RS .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (08) :2017-2022

[4]

CANTON E, 2002, REV ESP QUIM, V15, P341

[5] In vitro activities of four novel triazoles against Scedosporium spp. [J].

Carrillo, AJ ;

Guarro, J .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2001, 45 (07) :2151-2153

[6] Comparison of a new triazole, posaconazole, with itraconazole and amphotericin B for treatment of histoplasmosis following pulmonary challenge in immunocompromised mice [J].

Connolly, P ;

Wheat, LJ ;

Schnizlein-Bick, C ;

Durkin, M ;

Kohler, S ;

Smedema, M ;

Goldberg, J ;

Brizendine, E ;

Loebenberg, D .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (10) :2604-2608

[7] Activity of posaconazole in treatment of experimental disseminated zygomycosis [J].

Dannaoui, E ;

Meis, JFGM ;

Loebenberg, D ;

Verweij, PE .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (11) :3647-3650

[8] Comparison of in vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts [J].

Espinel-Ingroff, A .

JOURNAL OF CLINICAL MICROBIOLOGY, 1998, 36 (10) :2950-2956

[9] In vitro studies of activities of the antifungal triazoles SCH56592 and itraconazole against Candida albicans, Cryptococcus neoformans, and other pathogenic yeasts [J].

Galgiani, JN ;

Lewis, ML .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (01) :180-183

[10] In vitro and in vivo activities of posaconazole against Coccidioides immitis [J].

González, GM ;

Tijerina, R ;

Najvar, LK ;

Bocanegra, R ;

Rinaldi, M ;

Loebenberg, D ;

Graybill, JR .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2002, 46 (05) :1352-1356